Ofatumumab – the first fully human monoclonal antibody approved for the treatment of multiple sclerosis
Currently, more than 15 molecules are already approved for the treatment of multiple sclerosis, and sometimes physicians encounter problems selecting a drug for therapy when considering patients with the initial equivalent characteristics. When selecting a drug, it is important to consider not only...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado: |
IMA-PRESS LLC
2023-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Assuntos: | |
| Acceso en liña: | https://nnp.ima-press.net/nnp/article/view/2151 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|